Skip to content
  • Sunday, 26 July 2026
  • 1:47 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Inflammatory Remodeling of the Bone Marrow Niche: New Insights into the Early Drivers of Clonal Hematopoiesis and Myelodysplastic Syndrome
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche: New Insights into the Early Drivers of Clonal Hematopoiesis and Myelodysplastic Syndrome

Dwi Wanna Jul 22, 2026 0

The human bone marrow serves as a prolific biological factory, generating millions of new blood and immune cells every second…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathway for Osteoporosis Treatment

Dwi Wanna Jul 18, 2026 0

The landscape of regenerative medicine and endocrinology has shifted following the landmark identification of a novel protein that serves as…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna Jul 8, 2026 0

In a landmark study that could redefine the clinical approach to metabolic bone diseases, a team of researchers led by…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna Jun 20, 2026 0

A breakthrough in skeletal biology has emerged from the Institute of Science Tokyo, where researchers have identified a previously misunderstood…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Microenvironment Drives the Early Progression of Myeloid Malignancies and Age-Related Blood Disorders

Dwi Wanna Jun 15, 2026 0

The human bone marrow is a site of frantic and essential biological activity, tasked with the constant generation of millions…

Read More
Stem Cell & Regenerative Medicine

Breakthrough Discovery of Fam102a Protein as Key Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna Jun 1, 2026 0

In a landmark study published in Nature Communications on January 2, 2025, a multidisciplinary team of researchers led by Professor…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna May 24, 2026 0

A breakthrough study led by researchers at the Institute of Science Tokyo has identified a critical protein, Fam102a (Family with…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator in Bone Remodeling Offers New Pathways for Osteoporosis Treatment

Dwi Wanna May 17, 2026 0

In a significant advancement for regenerative medicine and skeletal health, a team of researchers at the Institute of Science Tokyo…

Read More
Stem Cell & Regenerative Medicine

Inflammatory Remodeling of the Bone Marrow Niche Drives Early Progression of Myelodysplastic Syndromes and Clonal Hematopoiesis

Dwi Wanna May 16, 2026 0

Every second of every day, the human bone marrow performs a silent biological miracle, generating millions of fresh blood and…

Read More
Stem Cell & Regenerative Medicine

Discovery of Fam102a Protein as a Novel Bone Remodeling Factor Offers New Pathway for Osteoporosis Treatment

Dwi Wanna May 9, 2026 0

In a landmark study published in the journal Nature Communications on January 2, 2025, a research team led by Professor…

Read More

Posts pagination

1 2
Apotex Acquires Cumberland Pharmaceuticals’ Branded Drug Portfolio for $100 Million, Ushering in New Era for Both CompaniesPharma 50: The 50 best-selling drugs of FY2025The U.S. Botanic Garden wants you to stop and smell America’s state flowers.Breakthrough RNA Barcoding Technology Connectome-seq Revolutionizes Neural Circuit Mapping and Neurodegenerative Disease Research
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ